Viral infections contribute as a cause of 15–20% of all human cancers. Infection by
oncogenic viruses can promote different stages of carcinogenesis. Among many types of …

Introduction Cervical cancer is the leading cause of cancer deaths in women in the
develo** world. New technologies have been developed to allow for more rapid, cost …

Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …

ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Background. Baseline information on human papillomavirus (HPV) prevalence and type
distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the …

Although most cervical human papillomavirus type 16 (HPV16) infections become
undetectable within 1–2 years, persistent HPV16 causes half of all cervical cancers. We …

Human papillomaviruses (HPVs) are a family of small double-stranded DNA viruses that
have a tropism for the epithelia of the genital and upper respiratory tracts and for the skin …

Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …